Related Experiment Video
Updated: Feb 27, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.2K
Mesenchymal stem cell treatment for IPF-time for phase 2 trials?
Katerina M Antoniou1, Konstantinos Karagiannis1, Eliza Tsitoura1
1Department of Respiratory Medicine and Laboratory of Molecular and Cellular Pulmonology, Faculty of Medicine, University of Crete, Crete, Greece.
The Lancet. Respiratory Medicine
|July 1, 2017
Summary
No abstract available in PubMed .
Related Concept Videos
01:19Mesenchymal Stem Cells
5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K